EX-10.1 4 d298993dex101.htm NOTE AND WARRANT PURCHASE AGREEMENT EXECUTION VERSION NOTE AND WARRANT PURCHASE AGREEMENTNote and Warrant Purchase Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis Note and Warrant Purchase Agreement (this “Agreement”) is dated as of February 10, 2012, among Marina Biotech, Inc., a Delaware corporation (the “Company”), MDRNA Research, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Research”), and Cequent Pharmaceuticals, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Cequent” and, together with the Company and Research, the “Companies”)), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
NOTE AND WARRANT PURCHASE AGREEMENTNote and Warrant Purchase Agreement • February 13th, 2012 • Marina Biotech, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 13th, 2012 Company Industry JurisdictionThis Note and Warrant Purchase Agreement (this “Agreement”) is dated as of February 10, 2012, among Marina Biotech, Inc., a Delaware corporation (the “Company”), MDRNA Research, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Research”), and Cequent Pharmaceuticals, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Cequent” and, together with the Company and Research, the “Companies”)), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
NOTE AND WARRANT PURCHASE AGREEMENTNote and Warrant Purchase Agreement • December 24th, 2009 • MDRNA, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 24th, 2009 Company Industry JurisdictionThis Note and Warrant Purchase Agreement (this “Agreement”) is dated as of December 22, 2009, among MDRNA, Inc., a Delaware corporation (the “Company”), MDRNA Research, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Research” and, together with the Company, the “Companies”)), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).